SCHEMBL4800141

SCHEMBL4800141

CCCCOC(=O)C1CC2CCCCC2N1C(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
ACE P12821 5/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FKBP1A P62942 4/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
SCN1A P35498 1/20 0.39
SCN2A Q99250 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798679 0.93 FFAR2 (0.45) FFAR2ACEMEN1KMT2AUSP2
SCHEMBL4800187 0.89 ACE (0.48) FFAR2ACEMEN1KMT2AUSP2
SCHEMBL4802081 0.84 CYP3A4 (0.46) L3MBTL1ACEMEN1KMT2AUSP2
SCHEMBL4800042 0.83 FFAR2 (0.44) FFAR2ACEMEN1KMT2AUSP2
SCHEMBL4798155 0.82 ACE (0.41) L3MBTL1ACEMEN1KMT2AUSP2
SCHEMBL4800296 0.82 FFAR2 (0.52) FFAR2MEN1KMT2AKDM4ECYP3A4
SCHEMBL4798814 0.80 FFAR2 (0.47) FFAR2ACEMEN1KMT2AUSP2
SCHEMBL4798437 0.80 FFAR2 (0.44) FFAR2ACEMEN1KMT2AUSP2
SCHEMBL4802516 0.80 CYP3A4 (0.49) KMT2AFKBP1AKDM4ECYP3A4
SCHEMBL15825448 0.80 ACE (0.39) L3MBTL1ACEMEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439036-B2 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-10-21 US disclosed
EP-1536017-B1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL CO (JP) 2007-04-18 EP disclosed
EP-1536017-A2 Process for producing optically active octahydro-1H-indole-2-carboxylic acid Sumitomo Chemical Company, Limited (JP) 2005-06-01 EP disclosed
US-20050106690-A1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050106690-A1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid IDO1, IDO2, APEH FFAR2 355/4885L3MBTL1 2864/4885ACE 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.